The Continuing Search for a Succinylcholine Replacement

Anesthesiology

Volumn 100, Issue 4, 2004, Pages 763-764

  Caldwell, James E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; EDROPHONIUM; GW 280430A; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; UNCLASSIFIED DRUG;

BRONCHOSPASM; CLINICAL TRIAL; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; EDITORIAL; ENDOTRACHEAL INTUBATION; HISTAMINE RELEASE; HUMAN; PRIORITY JOURNAL; SIDE EFFECT;

ANIMALS; HUMANS; ISOQUINOLINES; NEUROMUSCULAR DEPOLARIZING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE;

EID: 1642306236     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200404000-00002     Document Type: Editorial

References (18)

1. Savarese JJ, Caldwell JE, Lien CA, Miller RD: Pharmacology of muscle relaxants and their antagonists, Anesthesia, 5th edition. Edited by Miller RD. New York, Churchill Livingstone, 2000, pp 412-90
2. Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ: Clinical pharmacology of GW280430A in humans. ANESTHESIOLOGY 2004; 100:768-73
3. Heerdt PM, Kang R, The' A, Hashim M, Mook RJ Jr, Savarese JJ: Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs. ANESTHESIOLOGY 2004; 100:846-51
4. Savarese JJ, Belmont MR, Hashim MA, Mook RA Jr, Boros EE, Samano V, Patel SS, Feldman PL, Schultz J-AI, McNulty M, Spitzer T, Cohn DL, Morgan P, Wastila WB: Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium. ANESTHESIOLOGY 2004; 100:835-45
5. Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA Jr, Feldman PL, Savarese JJ, Belmont MR, Bigham EC, Boswell GE, Hashim MA, Patel SS, Wisowaty JC, Bowers GD, Moseley CL, Walsh JS, Reese MJ, Rutkowske RD, Sefler AM, Spitzer TD: Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys. J Med Chem 2003; 46:2502-15
6. McNulty M, Brown A, Johnson T, Spitzer TD, Savarese J: The ultra-short acting nondepolarizing relaxant GW280430A undergoes rapid degradation by chemical mechanisms. ANESTHESIOLGY 2000; 93:A-1037
7. Wright PM, Caldwell JE, Miller RD: Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. ANESTHESIOLOGY 1994; 81:1110-5
8. Kopman AF, Klewicka MM, Neuman GG: Reexamined: The recommended endotracheal intubating dose for nondepolarizing neuromuscular blockers of rapid onset. Anesth Analg 2001; 93:954-9
9. Kopman AF, Yee PS, Neuman GG: Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. ANESTHESIOLOGY 1997; 86:765-71
10. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, Kuylenstiema R: Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: Simultaneous videomanometry and mechanomyography of awake human volunteers. ANESTHESIOLOGY 1997; 87:1035-43
11. Dhonneur G, Kirov K, Slavov V, Duvaldestin P: Effects of an intubating dose of succinylcholine and rocuronium on the larynx and diaphragm: An electromyographic study in humans. ANESTHESIOLOGY 1999; 90:951-5
12. Savarese JJ, Wastila WB: The future of the benzylisoquinolinium relaxants. Acta Anaesthesiol Scand Suppl 1995; 106:91-3
13. Pino RM, Ali HH, Denman WT, Barrett PS, Schwartz A: A comparison of the intubation conditions between mivacurium and rocuronium during balanced anesthesia. ANESTHESIOLOGY 1998; 88:673-8
14. Motamed C, Donati F: Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults. Can J Anaesth 2000; 47:225-31
15. Doenicke AW, Czeslick E, Moss J, Hoemecke R: Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 1998; 87:434-8
16. Rajchert DM, Pasquariello CA, Watcha MF, Schreiner MS: Rapacuronium and the risk of bronchospasm in pediatric patients. Anesth Analg 2002; 94:488-93
17. Kahwaji R, Bevan DR, Bikhazi G, Shanks CA, Fragen RJ, Dyck JB, Angst MS, Matteo R: Dose-ranging study in younger adult and elderly patients of ORG 9487, a new, rapid-onset, short-duration muscle relaxant. Anesth Analg 1997; 84:1011-8
18. Moore EW, Hunter JM: The new neuromuscular blocking agents: Do they offer any advantages? Br J Anaesth 2001; 87:912-25